NCT04487925View on ClinicalTrials.gov

Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders

PHASE4RecruitingINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
Ovarian ReservePoor RespondersIVF
Interventions
DRUG

A single Gonadotropin-Releasing Hormone (GnRH) antagonist corifollitropin alfa (CFA) stimulation

CFA will be administered in combination with Follitropin beta.

DRUG

Up to three modified natural cycles with Follitropin beta.

Follitropin beta in a low dose will be given.

Trial Locations (1)

9000

RECRUITING

University Hospital Ghent, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT04487925 - Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders | Biotech Hunter | Biotech Hunter